je.st
news
Home
› GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development
GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development
2016-01-25 04:31:25| drugdiscoveryonline News Articles
GeneOne Life Science (KSE:011000) today announced the initiation of a collaborative research program with Inovio Pharmaceuticals (NASDAQ:INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.
Tags: life
development
science
virus
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||